Incivek

Indicated For

Hepatitis C genotype 1

About This Medication

# Incivek (telaprevir) Patient Guide: How to Get Incivek at Low or No Cost **Important Notice: Incivek (telaprevir) has been discontinued by the manufacturer, Vertex Pharmaceuticals. There is no current patient assistance program (PAP) available for this medication as of 2026.** This guide provides historical information about the former program for reference, but patients should consult healthcare providers for modern hepatitis C treatments and assistance options.[1][5] ## About Incivek (telaprevir) Incivek, known generically as **telaprevir**, was an oral medication approved by the FDA in May 2011 as a direct-acting antiviral (DAA) for treating **genotype 1 chronic hepatitis C virus (HCV)** in adults with compensated liver disease, including cirrhosis.[4] It targeted the HCV NS3/4A protease enzyme essential for viral replication.[6] **Incivek was never used alone.** It required combination with **peginterferon alfa** and **ribavirin** for 12 weeks, followed by additional weeks of the other two drugs based on viral response and treatment history (total 24-48 weeks).[3][4] Dosage was 750 mg three times daily (7-9 hours apart) with food.[4] Clinical trials showed strong results: 79% of treatment-naïve patients achieved sustained viral response (SVR, or cure) vs. 46% with interferon/ribavirin alone. Prior relapsers saw 86% SVR vs. 22%; partial responders 59% vs. 15%; null responders 32% vs. 5%.[6] Common side effects included rash, anemia, fatigue, itching, nausea, and anal discomfort. Serious risks: severe rash (including Stevens-Johnson syndrome), anemia requiring transfusions, and drug interactions.[3][4] **Why was it discontinued?** Newer, safer, shorter oral DAAs (e.g., sofosbuvir-based regimens) replaced older interferon combinations like Incivek starting around 2013-2014 due to better efficacy, fewer side effects, and no interferon.[1] Incivek is no longer manufactured or available via prescription.[1][5] ## Who Qualifies for Assistance? When active (2011-~2014), Vertex offered **Vertex GPS (Guidance & Patient Support)** for Incivek, including multiple aid types:[1][5] - **Vertex Free Medicine Program**: Free Incivek for uninsured patients (not on other benefits) with household income ≤ **$100,000/year**.[1] - **Co-Pay Support**: Covered up to 20% of Incivek costs for privately insured patients.[2] - **Case Management**: Free help researching insurance, appeals, and other aid via Vertex case managers.[1] - **Donations to PAN Foundation**: Co-pay help for underinsured HCV patients.[1] **No formal FPL (Federal Poverty Level) thresholds** were specified beyond the $100K cap for free drug; eligibility focused on lack of insurance/coverage.[1] Medicare patients might access via PAN or other routes, but program targeted uninsured/underinsured primarily.[1][5] ## Income Eligibility Breakdown | Household Size | Estimated Annual Income Limit (Free Medicine Program)* | |----------------|-----------------------------------------------------| | 1 person | ≤ $100,000 | | 2 people | ≤ $100,000 (household total) | | 3 people | ≤ $100,000 (household total) | | 4+ people | ≤ $100,000 (household total) | *Historical; flat $100K household cap, not scaled by FPL or size.[1] Co-pay aid had separate private insurance criteria.[2] **Today: No active program.** ## Insurance Requirements - **Free Medicine**: Required **no insurance** or other coverage for Incivek.[1] - **Co-Pay Support**: Needed **private insurance** covering Incivek (Vertex paid up to 20% coinsurance).[2] - **Medicare/Government Insurance**: Not directly eligible for free drug; case managers helped with appeals or alternatives like PAN Foundation.[1][5] Vertex GPS assisted **all patients** with insurance navigation, regardless of type.[1][5] ## Step-by-Step Application Process (Historical) 1. **Contact Vertex GPS**: Call **1-855-837-8394** or visit www.incivek.com/vertex-guidance-patient-support (now defunct).[5] 2. **Consult Your Doctor**: Get Incivek prescription + proof of HCV diagnosis (genotype 1). 3. **Case Manager Assignment**: Free specialist reviews insurance, income, and eligibility. 4. **Submit Documents**: Income proof (tax returns), insurance details (or proof of none), prescription, doctor's statement.[1] 5. **Approval/Processing**: If eligible, medication shipped free or co-pay voucher issued. **Today**: No applications accepted. Use resources like NeedyMeds, RxAssist, or PAN for current HCV drugs.[5] ## Timeline and Delivery - **Processing**: Not specified; case managers expedited (days to weeks).[1] - **Delivery**: Free shipping to home/doctor via specialty pharmacy.[1] - **Supply Duration**: 12-week course initially; reauthorized as needed.[4] ## If Denied or No Longer Eligible - **Appeal**: Case managers helped with insurance appeals.[1] - **Alternatives**: - **PAN Foundation** (co-pay aid for HCV).[1][5] - **NeedyMeds/RxAssist** databases for other programs.[5] - **Current HCV Treatments**: Modern DAAs via Gilead, AbbVie PAPs (e.g., Harvoni, Mavyret) – often 400% FPL, low/no cost.[5] - **ADAP/State Programs**: For uninsured/underinsured.[5] **No biosimilars** for telaprevir (discontinued DAA).[ ] ## Reauthorization and Refills 12-week Incivek course; doctor requested extensions via GPS. Case managers handled refills.[1][4] ## Disclaimer This guide is for **educational purposes only** and reflects a **discontinued program**.[1][5] Incivek/telaprevir is **no longer available**.[1] Do not seek this drug; it poses risks without modern standards. **Consult your doctor** for current genotype 1 HCV options (e.g., glecaprevir/pibrentasvir, sofosbuvir/velpatasvir) with active PAPs. Assistance info may change; verify via official sources. Not medical/financial advice. Word count: 942.

Program information last verified: March 30, 2026